BioMimetic and Praxis talking?

Okay, there are probably circumstances that make this a non-starter, but here: BioMimetic Therapeutics, Middle Tennessee's primary life-sciences hopeful, told investor analysts during a Q2-results conference Aug. 11 that efforts to recruit needed numbers of patients for key clinical trials have lagged pretty severely since March. Summer vacations, the price of gas for followup visits and overall economic conditions that might reduce elective surgeries were cited. Analysts questioned politely, but repeatedly the recruitment effort, which management acknowledged is "the most important issue for our company." Then, yesterday, Brentwood-based Praxis Communications, which helps pharma and biotech companies recruit patients for trials, announced a new-and-improved version of PraxisDirect 2.0, a software-as-service tool for recruiting and managing patient data for trials. (As of this morning, Praxis hadn't posted their release on their site.) At a distance, 'inquiring minds' wonder how often such companies talk with one another.